From: "Jeffrey E." <[email protected]> To: Donald Rubin Subject: Re: Placebo effects, EB, etc. Date: Wed, 07 Dec 2016 17:47:42 +0000 i might come up again, will know totnrow. let you know. On Wed, Dec 7, 2016 at 1:47 PM, Donald Rubin aa wrote: Think so. Where will you be? On Dec 7, 2016, at 12:25 PM, Jeffrey E. [email protected]> wrote: ar you around on the weekend in cambridge.? On Wed, Dec 7, 2016 at 1:10 PM, Donald Rubin wrote: OK. I'll get back to you after I make contact with Adriaan again, and my plans settle a bit. On Dec 7, 2016, at 10:38 AM, jeffrey E. <jeevacation®gmail.com> wrote: three way skype for 3. and yes 1 face to face On Wed, Dec 7, 2016 at 11:37 AM, Donald Rubin <e wrote: Different ways to follow up. 1. The next time that we're in the same town, we could talk about the statistical ideas underlying ways to disentangle placebo effects from biological effects of drugs and why that's important for FDA approvals and for prescripts in the docs office — different answers, I think. 2. I can send some recent things on the topic of placebo response, which are still not that wonderfully written. 3. If interested in exploring investing in EB, I can put you in touch with Adriaan, who lives in Amsterdam. Are any of these appealing? I prefer 1 to 2. I think a face to face version of 3 could be arranged either here or there. Let me know. On Dec 7, 2016, at 9:35 AM, jeffrey E. <jeevacation®gmail.com> wrote: I'm always interested in unique idea On Wed, Dec 7, 2016 at 10:12 AM Donald Rubin < > wrote: EFTA01059770